Clinical Trial Site

Tempe, Arizona 85283

1 studies enrolling now · 11 studies all time

What they study most

Healthy, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants — Completed
• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension — Completed
• Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) — Completed
• A Study of the Effects of Food and Age on Danicopan — Completed
• Study of ALXN2050 in Healthy Adult Participants of Japanese Descent — Completed
• Study of the Metabolism of Danicopan in Healthy Adults — Completed
• A Study of the Cardiac Effects of ALXN2050 in Healthy Adults — Completed
• A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults — Completed
• A Study of the Cardiac Effects of Danicopan in Healthy Adults — Completed